Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technologysort descending Institution Stage Project Objective Details
HIV-related Lymphoma,
HIV/AIDS
Adult Stem Cell Gene-modified, personalized cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Heart Disease iPS Cell Model system development UC Berkeley
Proof of Concept
Hearing Loss iPS Cell Model system development USC
Proof of Concept, Tool/Resources/Bottleneck
COVID-19,
Respiratory Disorders
Adult Stem Cell Model system development UCLA
Development Candidate, Proof of Concept, Tool/Resources/Bottleneck
Blood Disorders iPS Cell Model system development Stanford
Research Insights, Tool/Resources/Bottleneck
Ovarian Cancer Cancer Stem Cell Nucleic acid based therapy Loma Linda University
Proof of Concept
Intervertebral disc degeneration Adult Stem Cell Personalized cell therapy Ankasa
IND
Multiple Myeloma Adult Stem Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Bladder or Urinary Tract Disorder,
Incontinence
iPS Cell Personalized cell therapy Stanford
Pre-IND/IDE or Equivalent
Muscular Dystrophy Embryonic Stem Cell,
iPS Cell
Personalized cell therapy UCLA
Development Candidate
Heart Disease iPS Cell Personalized cell therapy UC Davis
Proof of Concept
HIV/AIDS Personalized cell therapy COH
IND
Age-related macular degeneration iPS Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Corneal Damage Adult Stem Cell Personalized cell therapy UCLA
IND
Type 1 diabetes Adult Stem Cell Personalized cell therapy Caladrius Biosciences
Clinical Trial, Phase 2
Corneal Damage Adult Stem Cell Personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Vascular Disease iPS Cell Personalized cell therapy PAVIR
Proof of Concept, Research Insights
Amyotrophic Lateral Sclerosis Adult Stem Cell Personalized cell therapy BrainStorm
Clinical Trial, Phase 3
Skeletal/Smooth Muscle disorders Adult Stem Cell Protein/peptide therapy Stanford
Research Insights
Hearing Loss Adult Stem Cell Protein/peptide therapy Stanford
Development Candidate, Proof of Concept
Vision Loss iPS Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Autism iPS Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
Skeletal/Smooth Muscle disorders Adult Stem Cell Small molecule therapy Stanford
Development Candidate
Bone or Cartilage Disease Adult Stem Cell Small molecule therapy MAX BioPharma
Pre-IND/IDE or Equivalent
Colon Cancer Cancer Stem Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy UCLA
Development Candidate, Proof of Concept
Osteonecrosis Adult Stem Cell Small molecule therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Arthritis,
Osteoarthritis
Adult Stem Cell Small molecule therapy Calibr
Clinical Trial, Phase 1 or Phase 1/2
COVID-19 iPS Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
COVID-19 iPS Cell Small molecule therapy USC
Development Candidate, Proof of Concept
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Small molecule therapy UCSD
Pre-IND/IDE or Equivalent
Heart Disease,
Neurological Disorders
Embryonic Stem Cell,
iPS Cell
Tissue engineering Gladstone
Proof of Concept, Research Insights
Neurological Disorders,
Zika virus
Adult Stem Cell,
iPS Cell
Vaccine UCLA
Development Candidate

Pages

Icon for csv export